Skip to main content
Australian Womens survey, from 25 467 responders the prevalence of #RA varies by how defined - 3·9% for self-reported R

Dr. John Cush RheumNow

2 years ago
Australian Womens survey, from 25 467 responders the prevalence of #RA varies by how defined - 3·9% for self-reported RA, 1·9% based on the medication dispensed, and 0·5% by self-reported medication use definitions. https://t.co/2FUwftajlG https://t.co/4a5CIfw8hS
A recent presentation at the 2024 Society of Cardiovascular Computed Tomography meeting by Brittany Weber MD, PhD (Brigham and Women’s Hospital) has shown that incidental findings of coronary artery calcium on chest CTs in patients with immune-mediated inflammatory diseases may be associated with poorer outcomes, even if they don’t have preexisting atherosclerotic cardiovascular disease.
A study from the Leiden Early Arthritis Clinic shows that is rheumatoid arthritis (RA) is diagnosed within 12 weeks after symptom onset, treatment costs were lower in both autoantibody-negative and autoantibody-positive RA. The rheumatologist mantra is diagnose early, treat early and aggressively, to yield better outcomes. But does it translate to a lower cost of care? 
3 yr German laboratory study of 71,597 laboratory tests, found 238 positive tests for 13 myositis autoAbs in 209 patien

Dr. John Cush RheumNow

2 years ago
3 yr German laboratory study of 71,597 laboratory tests, found 238 positive tests for 13 myositis autoAbs in 209 patients. Pos. results due to Idiopathic inflammatory myopathy in 37(18%), other inflammatory rheum Dz 90 (43%) or NO Rheum Dx 82 (39%) https://t.co/KKg0X1AyU1 https://t.co/FfVfufaUm4
JAK Inhibitors Reduce Macular Degeneration

Insurance claims data showed that patients with autoimmune disorders who to

Dr. John Cush RheumNow

2 years ago
JAK Inhibitors Reduce Macular Degeneration Insurance claims data showed that patients with autoimmune disorders who took JAK inhibitors had lower rates of AMD, hinting that the drugs might treat the common eye disease. https://t.co/bx0UCp0o3r https://t.co/FXSlcFHYXI
Geography of Arthritis-attributable Pain in the USA
The journal Pain highlights geographic differences in arthritis pain

Dr. John Cush RheumNow

2 years ago
Geography of Arthritis-attributable Pain in the USA The journal Pain highlights geographic differences in arthritis pain and outcomes, mainly in the Deep South and Appalachia. Severe arthritis pain is more prevalent in the SW, PNW, GA, FL, and ME regions. https://t.co/e4VuUDWoQt https://t.co/onHbLjAyHx
Updated EULAR Recommendations on the Treatment of Systemic Sclerosis

Medscape has published an overview to the 2024 up

Dr. John Cush RheumNow

2 years ago
Updated EULAR Recommendations on the Treatment of Systemic Sclerosis Medscape has published an overview to the 2024 updated recommendations for the treatment of SSc presented in Vienna at EULAR 2024. https://t.co/rmBIfNzJcu https://t.co/uZ2JUdsecZ
Retrospective study, biopsy-proven Lupus Nephritis pts - 35 of 115 pts (30%) were ANCA positive. ANCA+ LN pts had higher

Dr. John Cush RheumNow

2 years ago
Retrospective study, biopsy-proven Lupus Nephritis pts - 35 of 115 pts (30%) were ANCA positive. ANCA+ LN pts had higher dz activity, predominantly proliferative LN, require more immunosuppressives (CTX, MMF) to achieve remission. https://t.co/jzU8fPYHps https://t.co/E7pMDWJmKt
Systemic sclerosis sine scleroderma

Systemic sclerosis sine scleroderma (ssSSc), which accounts for nearly 10% of syst

Dr. John Cush RheumNow

2 years ago
Systemic sclerosis sine scleroderma Systemic sclerosis sine scleroderma (ssSSc), which accounts for nearly 10% of systemic sclerosis (SSc) patients and was first described in 1962, is a subset of SSc. https://t.co/5NMykTHEtK https://t.co/JNo27zaTrJ
174 Active RA pts not responding to MTX were started on TCZ. High GM-CSF (> 5 ng/ml and > 10 ng/ml) at basel

Dr. John Cush RheumNow

2 years ago
174 Active RA pts not responding to MTX were started on TCZ. High GM-CSF (> 5 ng/ml and > 10 ng/ml) at baseline were the independent predictors of poor response to TCZ at Wk24. high GM-CSF had signif higher DAS28-ESR & cytokine levels at baseline https://t.co/AreLBseJDq https://t.co/OyIOkiUOT1
268/279 SLE pts w/ kidney biopsy for proteinuria were Dx w/ lupus nephritis. Proliferative LN (III/IV+V) had higher leve

Dr. John Cush RheumNow

2 years ago
268/279 SLE pts w/ kidney biopsy for proteinuria were Dx w/ lupus nephritis. Proliferative LN (III/IV+V) had higher levels of C1q, chromatin, dsDNA, ribosomal P Abs. C1q & dsDNA independently assoc w/ proliferative LN. AutoAbs decreased in proliferative LN https://t.co/oq3JhrFlz8 https://t.co/nxQBZvoOzP
Full read overview of myositis associated - ILD (and treatments), including:
- Case examples
- Antisynthetase Syndrome

Dr. John Cush RheumNow

2 years 1 month ago
Full read overview of myositis associated - ILD (and treatments), including: - Case examples - Antisynthetase Syndrome - Anti-MDA5 Amyopathic DM - Interstitial Lung Disease in Myositis https://t.co/PhfuuBHOYf https://t.co/OC1GmWkYyO
Enhance your clinical practice with insights from the EULAR 2024 Poster Hall Presentations, now on https://t.co/V10S4oVF

Dr. John Cush RheumNow

2 years 1 month ago
Enhance your clinical practice with insights from the EULAR 2024 Poster Hall Presentations, now on https://t.co/V10S4oVFsv. This year's conference showcases pivotal research in rheumatology. Visit https://t.co/gL38TVZRkM to stay at the forefront of medical innovation. https://t.co/cZontmAPTq
×